BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03379051-completion@plaintrial.com
DTSTAMP:20261027T224652Z
DTSTART;VALUE=DATE:20220616
SUMMARY:Phase I/II Study of Venetoclax or Lenalidomide in Combination With 
 Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL
  and NHL — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03379051
URL:https://plaintrial.com/trial/NCT03379051
END:VEVENT
END:VCALENDAR